PMID- 16303765 OWN - NLM STAT- MEDLINE DCOM- 20060307 LR - 20210209 IS - 0021-9258 (Print) IS - 1083-351X (Electronic) IS - 0021-9258 (Linking) VI - 281 IP - 4 DP - 2006 Jan 27 TI - Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. PG - 2061-70 AB - We have investigated the effects of hypoxia and myocardial ischemia/reperfusion on the structure and function of cytochrome c oxidase (CcO). Hypoxia (0.1% O(2) for 10 h) and cAMP-mediated inhibition of CcO activity were accompanied by hyperphosphorylation of subunits I, IVi1, and Vb and markedly increased reactive O(2) species production by the enzyme complex in an in vitro system that uses reduced cytochrome c as an electron donor. Both subunit phosphorylation and enzyme activity were effectively reversed by 50 nm H89 or 50 nm myristoylated peptide inhibitor (MPI), specific inhibitors of protein kinase A, but not by inhibitors of protein kinase C. In rabbit hearts subjected to global and focal ischemia, CcO activity was inhibited in a time-dependent manner and was accompanied by hyperphosphorylation as in hypoxia. Additionally, CcO activity and subunit phosphorylation in the ischemic heart were nearly completely reversed by H89 or MPI added to the perfusion medium. Hyperphosphorylation of subunits I, IVi1, and Vb was accompanied by reduced subunit contents of the immunoprecipitated CcO complex. Most interestingly, both H89 and MPI added to the perfusion medium dramatically reduced the ischemia/reperfusion injury to the myocardial tissue. Our results pointed to an exciting possibility of using CcO activity modulators for controlling myocardial injury associated with ischemia and oxidative stress conditions. FAU - Prabu, Subbuswamy K AU - Prabu SK AD - Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA 19104, USA. FAU - Anandatheerthavarada, Hindupur K AU - Anandatheerthavarada HK FAU - Raza, Haider AU - Raza H FAU - Srinivasan, Satish AU - Srinivasan S FAU - Spear, Joseph F AU - Spear JF FAU - Avadhani, Narayan G AU - Avadhani NG LA - eng GR - R01 GM049683/GM/NIGMS NIH HHS/United States GR - GM 49683/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20051122 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Isoquinolines) RN - 0 (Peptides) RN - 0 (Reactive Oxygen Species) RN - 0 (Sulfonamides) RN - 7U1EE4V452 (Carbon Monoxide) RN - EC 1.9.3.1 (Electron Transport Complex IV) RN - EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases) RN - EC 2.7.11.13 (Protein Kinase C) RN - M876330O56 (N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide) RN - S88TT14065 (Oxygen) SB - IM MH - Animals MH - Carbon Monoxide MH - Cells, Cultured MH - Cyclic AMP-Dependent Protein Kinases/chemistry/metabolism/*physiology MH - Electron Transport Complex IV/*metabolism MH - *Hypoxia MH - Immunoblotting MH - Immunoprecipitation MH - Ischemia/*pathology MH - Isoquinolines/pharmacology MH - Macrophages/metabolism MH - Male MH - Mice MH - Mitochondria/metabolism MH - Monocytes/metabolism MH - Myocardial Ischemia MH - Myocardium/*pathology MH - Oxidative Stress MH - Oxygen/metabolism MH - Peptides/chemistry MH - Perfusion MH - Phosphorylation MH - Protein Kinase C/metabolism MH - Rabbits MH - Reactive Oxygen Species MH - Reperfusion Injury MH - Sulfonamides/pharmacology MH - Time Factors PMC - PMC4271455 MID - NIHMS515873 EDAT- 2005/11/24 09:00 MHDA- 2006/03/08 09:00 PMCR- 2014/12/19 CRDT- 2005/11/24 09:00 PHST- 2005/11/24 09:00 [pubmed] PHST- 2006/03/08 09:00 [medline] PHST- 2005/11/24 09:00 [entrez] PHST- 2014/12/19 00:00 [pmc-release] AID - S0021-9258(20)70757-X [pii] AID - 10.1074/jbc.M507741200 [doi] PST - ppublish SO - J Biol Chem. 2006 Jan 27;281(4):2061-70. doi: 10.1074/jbc.M507741200. Epub 2005 Nov 22.